Molecular interactions and inhibition of the SARS-CoV-2 main protease by a thiadiazolidinone derivative.

Academic Article

Abstract

  • We report molecular interactions and inhibition of the main protease (MPro ) of SARS-CoV-2, a key enzyme involved in the viral life cycle. By using a thiadiazolidinone (TDZD) derivative as a chemical probe, we explore the conformational dynamics of MPro via docking protocols and molecular dynamics simulations in all-atom detail. We reveal the local and global dynamics of MPro in the presence of this inhibitor and confirm the inhibition of the enzyme with an IC50 value of 1.39 ± 0.22 μM, which is comparable to other known inhibitors of this enzyme.
  • Authors

  • Andrzejczyk, Jacob
  • Jovic, Katarina
  • Brown, Logan M
  • Pascetta, Valerie G
  • Varga, Krisztina
  • Vashisth, Harish
  • Status

    Publication Date

  • November 2022
  • Keywords

  • Antiviral Agents
  • Azoles
  • COVID-19 Drug Treatment
  • Coronavirus 3C Proteases
  • Humans
  • Molecular Docking Simulation
  • Molecular Dynamics Simulation
  • Protease Inhibitors
  • SARS-CoV-2
  • Viral Nonstructural Proteins
  • docking
  • main protease
  • molecular dynamics
  • thiadiazolidinone
  • Digital Object Identifier (doi)

    Start Page

  • 1896
  • End Page

  • 1907
  • Volume

  • 90
  • Issue

  • 11